Skip to main content
logo
Innate Pharma S.A. (EPA:IPH)
France flag France · Delayed Price · Currency is EUR
1.540
+0.010 (0.65%)
Aug 3, 2026, 5:23 PM CET

Innate Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
144148160211264352
Market Cap Growth
-19.30%-7.67%-24.29%-19.93%-24.98%28.64%
Enterprise Value
132115104163184249
Last Close Price
1.531.601.932.623.294.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
1.612.994.3310.0410.0458.98
PS Ratio
15.9616.407.953.434.5814.24
PB Ratio
-6.62-6.8018.114.074.873.27
P/TBV Ratio
--18.114.105.025.56

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.6512.735.152.653.1910.07

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.04-1.043.510.770.780.41
Net Debt / Equity Ratio
0.540.54-5.63-1.01-1.09-0.70
Net Debt / EBITDA Ratio
0.220.220.996.164.931.75
Net Debt / FCF Ratio
0.220.226.831.603.011.27
Asset Turnover
0.100.100.140.330.250.09
Quick Ratio
1.141.142.503.513.211.67
Current Ratio
1.271.272.603.733.381.73
Return on Equity (ROE)
---162.91%-14.28%-71.75%-34.53%
Return on Assets (ROA)
-38.85%-38.85%-22.52%-4.23%-4.40%-10.40%
Return on Invested Capital (ROIC)
-207.17%----122.70%-173.03%
Return on Capital Employed (ROCE)
-207.20%-207.20%-66.10%-9.30%-10.40%-25.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-34.22%-33.30%-30.93%-3.58%-22.02%-15.02%
FCF Yield
-36.81%-35.82%-4.56%-15.58%-7.46%-16.89%
Buyback Yield / Dilution
-10.54%-10.54%-0.74%-1.02%-0.12%-0.77%